Clinical trial
Efficacy Study of Erythropoietin After Revascularization in Myocardial…
NCT00390832 · Deutsches Herzzentrum Muenchen, Other · Completed
Key facts
| NCT number | NCT00390832 |
|---|---|
| Title | Efficacy Study of Erythropoietin After Revascularization in Myocardial Infarction (REVIVAL-3) |
| Official title | Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Erythropoietin in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention (REVIVAL-3) |
| Acronym | REVIVAL-3 |
| Lead sponsor | Deutsches Herzzentrum Muenchen, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Myocardial Infarction, Angioplasty, Transluminal, Percutaneous Coronary |
| Intervention type | Drug, Other |
| Interventions | Erythropoietin, Placebo |
| Enrollment | 138 |
| Start date | Dec 1, 2006 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Oct 20, 2006 |
| Last update posted | Dec 17, 2010 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: